Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.

Yang WC, Hwang SJ; Taiwan Society of Nephrology..

Nephrol Dial Transplant. 2008 Dec;23(12):3977-82. doi: 10.1093/ndt/gfn406. Epub 2008 Jul 15.

PMID:
18628366
2.

End-stage renal disease in the Asian-Pacific region.

Lee G.

Semin Nephrol. 2003 Jan;23(1):107-14. Review.

PMID:
12563605
3.

The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan.

Yang WC, Hwang SJ, Chiang SS, Chen HF, Tsai ST.

Diabetes Res Clin Pract. 2001 Nov;54 Suppl 1:S47-54. Review.

PMID:
11580969
4.

[Course of chronic renal failure epidemiology and prediction of maintenance dialysis needs in France].

Jungers P, Robino C, Choukroun G, Touam M, Fakhouri F, Grünfeld JP.

Nephrologie. 2001;22(3):91-7. Review. French.

PMID:
11436669
5.

International Study of Health Care Organization and Financing for end-stage renal disease in France.

Durand-Zaleski I, Combe C, Lang P.

Int J Health Care Finance Econ. 2007 Sep;7(2-3):171-83. Review.

PMID:
17680359
6.

Current status of dialysis therapy in Korea.

Jin DC.

Korean J Intern Med. 2011 Jun;26(2):123-31. doi: 10.3904/kjim.2011.26.2.123. Epub 2011 Jun 1. Review.

7.
8.

Projecting the United States ESRD population: issues regarding treatment of patients with ESRD.

Szczech LA, Lazar IL.

Kidney Int Suppl. 2004 Sep;(90):S3-7. Review.

PMID:
15296500
9.

Primary health care strategies for the prevention of end-stage renal disease in Cuba.

Almaguer M, Herrera R, Alfonso J, Magrans C, Mañalich R, Martínez A.

Kidney Int Suppl. 2005 Aug;(97):S4-10. Review.

PMID:
16014098
10.

The end-stage renal disease program: trends over the past 18 years.

Port FK.

Am J Kidney Dis. 1992 Jul;20(1 Suppl 1):3-7. Review.

PMID:
1626554
11.

Diabetes: changing the fate of diabetics in the dialysis unit.

Broumand B.

Blood Purif. 2007;25(1):39-47. Epub 2006 Dec 14. Review.

PMID:
17170536
12.

End-stage renal disease in the United States: an update from the United States Renal Data System.

Foley RN, Collins AJ.

J Am Soc Nephrol. 2007 Oct;18(10):2644-8. Epub 2007 Jul 26. Review.

13.

Epidemiology, impact and preventive care of chronic kidney disease in Taiwan.

Hwang SJ, Tsai JC, Chen HC.

Nephrology (Carlton). 2010 Jun;15 Suppl 2:3-9. doi: 10.1111/j.1440-1797.2010.01304.x. Review.

PMID:
20586940
14.
15.

The organization and funding of the treatment of end-stage renal disease in Australia.

Harris A.

Int J Health Care Finance Econ. 2007 Sep;7(2-3):113-32. Review.

PMID:
17763938
16.

Worldwide demographics and future trends of the management of renal failure in the elderly.

Mignon F, Michel C, Mentre F, Viron B.

Kidney Int Suppl. 1993 Jun;41:S18-26. Review.

PMID:
8320916
17.

End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Dor A, Pauly MV, Eichleay MA, Held PJ.

Int J Health Care Finance Econ. 2007 Sep;7(2-3):73-111. Review.

PMID:
17653860
18.

International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.

Pontoriero G, Pozzoni P, Vecchio LD, Locatelli F.

Int J Health Care Finance Econ. 2007 Sep;7(2-3):201-15. Review.

PMID:
17641969
19.

The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.

Manns BJ, Mendelssohn DC, Taub KJ.

Int J Health Care Finance Econ. 2007 Sep;7(2-3):149-69. Review.

PMID:
17641968
20.

Funding ESRD care through charity: the paradigm of the National Kidney Foundation of Singapore.

Ramirez SP, Hsu SI, Nandakumar M, Friedman EA, Durai TT, Owen WF Jr.

Semin Nephrol. 2001 Jul;21(4):411-8. Review.

PMID:
11455530

Supplemental Content

Support Center